Bozic Carmen sold VRTX
June 18, 2026 · Form 4 insider transaction
Bozic Carmen sold 1,020 shares of Vertex Pharmaceuticals Incorporated at $462.17 per share, a transaction worth $471.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,020
Price
$462.17
Total value
$471.4K
InsiderBozic Carmen
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 18, 2026
Filing dateJune 23, 2026
Shares owned after15,933
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.